Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
BKD vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
BKD vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $3.37B | $10.28B |
| Revenue (TTM) | $3.11B | $5.27B |
| Net Income (TTM) | $-205M | $363M |
| Gross Margin | 13.5% | 15.2% |
| Operating Margin | 1.3% | 8.5% |
| Forward P/E | — | 23.4x |
| Total Debt | $6.66B | $4.15B |
| Cash & Equiv. | $279M | $504M |
BKD vs ENSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Brookdale Senior Li… (BKD) | 100 | 387.4 | +287.4% |
| The Ensign Group, I… (ENSG) | 100 | 402.4 | +302.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BKD vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BKD is the clearest fit if your priority is momentum.
- +110.1% vs ENSG's +31.9%
ENSG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
- 7.7% 10Y total return vs BKD's -21.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% revenue growth vs BKD's 4.8% | |
| Quality / Margins | 6.9% margin vs BKD's -6.6% | |
| Stability / Safety | Beta 0.42 vs BKD's 0.67 | |
| Dividends | 0.1% yield; 12-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +110.1% vs ENSG's +31.9% | |
| Efficiency (ROA) | 6.8% ROA vs BKD's -3.4%, ROIC 7.0% vs 0.2% |
BKD vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BKD vs ENSG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ENSG leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 1.7x BKD's $3.1B. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to BKD's -6.6%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.1B | $5.3B |
| EBITDAEarnings before interest/tax | $381M | $558M |
| Net IncomeAfter-tax profit | -$205M | $363M |
| Free Cash FlowCash after capex | $56M | $406M |
| Gross MarginGross profit ÷ Revenue | +13.5% | +15.2% |
| Operating MarginEBIT ÷ Revenue | +1.3% | +8.5% |
| Net MarginNet income ÷ Revenue | -6.6% | +6.9% |
| FCF MarginFCF ÷ Revenue | +1.8% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.0% | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +89.3% | +21.9% |
Valuation Metrics
BKD leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
On an enterprise value basis, ENSG's 25.9x EV/EBITDA is more attractive than BKD's 25.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.4B | $10.3B |
| Enterprise ValueMkt cap + debt − cash | $9.8B | $13.9B |
| Trailing P/EPrice ÷ TTM EPS | -12.77x | 30.13x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 23.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.18x |
| EV / EBITDAEnterprise value multiple | 25.92x | 25.88x |
| Price / SalesMarket cap ÷ Revenue | 1.08x | 2.03x |
| Price / BookPrice ÷ Book value/share | — | 4.63x |
| Price / FCFMarket cap ÷ FCF | — | 27.72x |
Profitability & Efficiency
ENSG leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-235 for BKD. On the Piotroski fundamental quality scale (0–9), ENSG scores 5/9 vs BKD's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -234.5% | +16.6% |
| ROA (TTM)Return on assets | -3.4% | +6.8% |
| ROICReturn on invested capital | +0.2% | +7.0% |
| ROCEReturn on capital employed | +0.3% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | — | 1.86x |
| Net DebtTotal debt minus cash | $6.4B | $3.7B |
| Cash & Equiv.Liquid assets | $279M | $504M |
| Total DebtShort + long-term debt | $6.7B | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | -0.03x | 88.33x |
Total Returns (Dividends Reinvested)
BKD leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BKD five years ago would be worth $21,485 today (with dividends reinvested), compared to $20,770 for ENSG. Over the past 12 months, BKD leads with a +110.1% total return vs ENSG's +31.9%. The 3-year compound annual growth rate (CAGR) favors BKD at 52.6% vs ENSG's 24.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +30.8% | +1.2% |
| 1-Year ReturnPast 12 months | +110.1% | +31.9% |
| 3-Year ReturnCumulative with dividends | +255.4% | +90.7% |
| 5-Year ReturnCumulative with dividends | +114.8% | +107.7% |
| 10-Year ReturnCumulative with dividends | -21.8% | +768.3% |
| CAGR (3Y)Annualised 3-year return | +52.6% | +24.0% |
Risk & Volatility
Evenly matched — BKD and ENSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than BKD's 0.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 0.42x |
| 52-Week HighHighest price in past year | $17.00 | $218.00 |
| 52-Week LowLowest price in past year | $6.07 | $129.91 |
| % of 52W HighCurrent price vs 52-week peak | +83.4% | +80.7% |
| RSI (14)Momentum oscillator 0–100 | 51.2 | 23.3 |
| Avg Volume (50D)Average daily shares traded | 3.2M | 352K |
Analyst Outlook
ENSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates BKD as "Buy" and ENSG as "Buy". Consensus price targets imply 26.4% upside for ENSG (target: $222) vs 24.6% for BKD (target: $18). ENSG is the only dividend payer here at 0.14% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $17.67 | $222.33 |
| # AnalystsCovering analysts | 12 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +0.1% |
| Dividend StreakConsecutive years of raises | 0 | 12 |
| Dividend / ShareAnnual DPS | — | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +0.2% |
ENSG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BKD leads in 2 (Valuation Metrics, Total Returns). 1 tied.
BKD vs ENSG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is BKD or ENSG a better buy right now?
For growth investors, The Ensign Group, Inc.
(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 4. 8% for Brookdale Senior Living Inc. (BKD). The Ensign Group, Inc. (ENSG) offers the better valuation at 30. 1x trailing P/E (23. 4x forward), making it the more compelling value choice. Analysts rate Brookdale Senior Living Inc. (BKD) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BKD or ENSG?
Over the past 5 years, Brookdale Senior Living Inc.
(BKD) delivered a total return of +114. 8%, compared to +107. 7% for The Ensign Group, Inc. (ENSG). Over 10 years, the gap is even starker: ENSG returned +768. 3% versus BKD's -21. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BKD or ENSG?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus Brookdale Senior Living Inc. 's 0. 67β — meaning BKD is approximately 59% more volatile than ENSG relative to the S&P 500.
04Which is growing faster — BKD or ENSG?
By revenue growth (latest reported year), The Ensign Group, Inc.
(ENSG) is pulling ahead at 18. 7% versus 4. 8% for Brookdale Senior Living Inc. (BKD). On earnings-per-share growth, the picture is similar: The Ensign Group, Inc. grew EPS 14. 1% year-over-year, compared to -24. 7% for Brookdale Senior Living Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BKD or ENSG?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus -8. 4% for Brookdale Senior Living Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ENSG leads at 8. 6% versus 0. 5% for BKD. At the gross margin level — before operating expenses — BKD leads at 20. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is BKD or ENSG more undervalued right now?
Analyst consensus price targets imply the most upside for ENSG: 26.
4% to $222. 33.
07Which pays a better dividend — BKD or ENSG?
In this comparison, ENSG (0.
1% yield) pays a dividend. BKD does not pay a meaningful dividend and should not be held primarily for income.
08Is BKD or ENSG better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +768. 3% 10Y return). Both have compounded well over 10 years (ENSG: +768. 3%, BKD: -21. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BKD and ENSG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BKD is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.